UBS Group’s ARYA Sciences Acquisition Corp IV Class A Odinary Shares ARYD Stock Holding History

UBS Group’s Portfolio ARYD Stock Details ARYD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2	Closed	-$23	–	10437
2024 Q2	$23	Buy	2 +1	+100%	+$11	﹤0.01%	9302
2024 Q1	$11	Buy	+1	New	+$11	﹤0.01%	9090
2023 Q4	–	Sell	-125	Closed	-$1.35K	–	10182
2023 Q3	$1.35K	Buy	+125	New	+$1.34K	﹤0.01%	7975
2022 Q4	–	Sell	-2,186	Closed	-$22K	–	11322
2022 Q3	$22K	Buy	2,186 +1	+0%	+$10	﹤0.01%	7286
2022 Q2	$21K	Buy	2,185 +1,000	+84%	+$9.8K	﹤0.01%	6838
2022 Q1	$12K	Sell	1,185 -409	-26%	-$4.02K	﹤0.01%	8218
2021 Q4	$16K	Sell	1,594 -2,454	-61%	-$24.4K	﹤0.01%	8189
2021 Q3	$41K	Buy	4,048 +2,500	+161%	+$25.2K	﹤0.01%	6510
2021 Q2	$17K	Buy	+1,548	New	+$16.5K	﹤0.01%	7533

UBS Group's ARYD Position: Q3 2024 in Review

UBS Group sold out of ARYA Sciences Acquisition Corp IV Class A Odinary Shares (ARYD) in Q3 2024, closing a stake of 2 shares — an estimated $23 sold.

UBS Group first reported a position in ARYD in Q2 2021 and held it in 9 quarters. The position peaked at $41K in Q3 2021. 0 funds tracked by Wall St. Rank hold ARYD as of Q3 2024.

UBS Group reported no remaining ARYA Sciences Acquisition Corp IV Class A Odinary Shares position as of Q3 2024 after selling out during the quarter.
UBS Group sold 2 ARYA Sciences Acquisition Corp IV Class A Odinary Shares shares in Q3 2024, an estimated $23.
UBS Group first reported a position in ARYA Sciences Acquisition Corp IV Class A Odinary Shares in Q2 2021 and held it in 9 quarters.
UBS Group's ARYA Sciences Acquisition Corp IV Class A Odinary Shares position peaked at $41K in Q3 2021.
0 funds tracked by Wall St. Rank held ARYA Sciences Acquisition Corp IV Class A Odinary Shares as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.